Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
CYB5R3 encodes cytochrome b5 reductase, which includes a membrane-bound form in somatic cells (anchored in the endoplasmic reticulum, mitochondrial and other membranes) and a soluble form in erythrocytes. Zusätzlich bieten wir Ihnen Cytochrome B5 Reductase 3 Kits (16) und Cytochrome B5 Reductase 3 Proteine (16) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 135 products:
Human Polyclonal CYB5R3 Primary Antibody für ICC, IF - ABIN4301429
Jakobs, Mikula, Havemeyer, Strzalkowska, Borowa-Chmielak, Dzwonek, Gajewska, Hennig, Ostrowski, Clement: The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice. in PLoS ONE 2014
Mouse (Murine) Polyclonal CYB5R3 Primary Antibody für ELISA, WB - ABIN4301428
Fernandez-Borja, Janssen, Verwoerd, Hordijk, Neefjes: RhoB regulates endosome transport by promoting actin assembly on endosomal membranes through Dia1. in Journal of cell science 2005
Data suggest that cytochrome b5 (CYB5 (zeige CYB5A Antikörper)) and cytochrome b5 reductase 3 (CYB5R3) can reduce human cytoglobin (CYGB (zeige CYGB Antikörper)) and zebrafish cytoglobins at rates up to 250-fold higher than those reported for the known physiological substrates, hemoglobin (zeige HBB Antikörper) and myoglobin (zeige MB Antikörper); the three proteins (CYB5 (zeige CYB5A Antikörper)+CYB5R3+CYGB (zeige CYGB Antikörper)) appear to constitute a metabolon involved in generation of nitric oxide.
CYB5R3 promotes colonization and metastasis formation and is a prognostic marker of disease-free and overall survival in estrogen receptor (zeige ESR1 Antikörper)-negative breast cancer.
Variants in CYB5A (zeige CYB5A Antikörper) and CYB5R3 should be considered in the evaluation of breast cancer risk in African American women.
Genetic variation in CYB5R3 is associated with methemoglobin levels in preterm infants receiving nitric oxide therapy.
The results unveil a potential mechanism of action by which CYB5R3 deficiency contributes to the pathophysiological underpinnings of neurological disorders in RHM patients.
Dapsone-associated methemoglobinemia in a patient with slow NAT2 (zeige SLC38A1 Antikörper)*5B haplotype and impaired cytochrome b5 reductase activity
A comprehensive overview of the study of structure and function of human cytochrome b5 reductase.
Data indicate that mitochondrial amidoxime reducing components 1 and 2 together with the electron transport proteins NADH-cytochrome b5 reductase (zeige CYB5RL Antikörper) (CYB5R) and cytochrome b5 (CYB5 (zeige CYB5A Antikörper)) catalyze the reduction of N-hydroxylated compounds such as amidoximes.
Population frequency and age of c.806C > T mutation in CYB5R3 gene as cause of recessive congenital methemoglobinemia in Yakutia.
Novel large deletion c.22-1320_633+1224del in the CYB5R3 gene from patients with hereditary methemoglobinemia
Nucleation is achieved by a mechanism involving APC (zeige APC Antikörper)-B dimerization and recruitment of multiple actin monomers. Further, APC (zeige APC Antikörper)-B nucleation activity is synergistic with its in vivo binding partner, the formin (zeige FMN1 Antikörper) mDia1
an N-terminal domain spanning residues 129-369(DID) is sufficient for auto-inhibition, but alone is not sufficient for RhoA (zeige RHOA Antikörper) relief of auto-inhibition, suggesting that sequences N-terminal to DID are important to RhoA (zeige RHOA Antikörper) binding.
Dia1 is required for the formation of the actin coat around endosomes downstream of RhoB, connecting membrane trafficking with the regulation of actin dynamics.
Dia1 and IQGAP1 (zeige IQGAP1 Antikörper) interact in cell migration and phagocytic cup formation.
This gene encodes cytochrome b5 reductase, which includes a membrane-bound form in somatic cells (anchored in the endoplasmic reticulum, mitochondrial and other membranes) and a soluble form in erythrocytes. The membrane-bound form exists mainly on the cytoplasmic side of the endoplasmic reticulum and functions in desaturation and elongation of fatty acids, in cholesterol biosynthesis, and in drug metabolism. The erythrocyte form is located in a soluble fraction of circulating erythrocytes and is involved in methemoglobin reduction. The membrane-bound form has both membrane-binding and catalytic domains, while the soluble form has only the catalytic domain. Alternate splicing results in multiple transcript variants. Mutations in this gene cause methemoglobinemias.
NADH-cytochrome b5 reductase 3
, NADH-cytochrome b5 reductase 3 membrane-bound form
, NADH-cytochrome b5 reductase 3 soluble form
, Diaphorase (NADH) (cytochrome b-5 reductase)
, diaphorase 1
, diaphorase 1 (NADH)
, NADH-cytochrome b5 reductase
, cytochrome b5 reductase 3